• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    C

    Clinical Centre of Kragujevac

    EST. 1818kc-kg.rs
    426论文总数
    3,821引用总数

    The Clinical Centre of Kragujevac (Serbian: Клинички Центар Крагујевац; abbr. КЦК / KCK) is a medical centre located in Kragujevac, Serbia. It serves as the main medical centre for both Kragujevac and Šumadija and Western Serbia..

    论文量&引用量时间轴

    机构学者

    排序
    Slobodan Jankovic
    Slobodan Jankovic
    University of Kragujevac
    论文:41引用:0H-index:0
    Dejan Petrovic
    Dejan Petrovic
    3Department of Urology and Nephrology, Clinical Center Kragujevac
    论文:16引用:0H-index:0
    Marko Folic
    Marko Folic
    University of Kragujevac, Faculty of Medical Sciences; University Clinical Centre Kragujevac, Department of Clinical Pharmacology
    论文:15引用:0H-index:0
    Vladimir Lj. Jakovljevic
    Vladimir Lj. Jakovljevic
    Department of Physiology, Faculty of Medical Sciences, University of Kragujevac
    论文:13引用:0H-index:0
    Biljana Vuletic
    Biljana Vuletic
    Clinical Centre Kragujevac Faculty of Medical Sciences, University of Kragujevac
    论文:11引用:0H-index:0
    Milovanovic Dragan R
    Milovanovic Dragan R
    Faculty of medical sciences Kragujevac, University of Kragujevac
    论文:11引用:0H-index:0
    Jasna Jevdjic
    Jasna Jevdjic
    Faculty of Medical Sciences, University of Kragujevac
    论文:10引用:0H-index:0
    Vesna D. Stankovic
    Vesna D. Stankovic
    Faculty of Medical Sciences, University of Kragujevac
    论文:10引用:0H-index:0
    Vladimir Miloradovic
    Vladimir Miloradovic
    Klinicki Centar Kragujevac
    论文:10引用:0H-index:0

    论文(426)

    年份
    起
    –
    止
    排序
    1Prediction of Recurrence and Recurrence-Free Survival Using Machine Learning Approaches among Stage I–II and III Melanoma Patients in Serbia
    I. Tanasković, I. Salatić, M. Recalde, B. Dujović, S. Matković, M. Đurkić, J. Filipović, A. Ivezić, B. Nikolin, N. Kolović, E. Milosavljević, M. Petronijević,
    2026EJC Skin Cancer(2026)
    引用
    AI阅读
    加入学术空间
    2Registry-based Survival Analysis of High-Risk Melanoma Patients in Serbia: the Impact of Adjuvant Treatment for Stage III Disease
    J. Pavlica, L. Kandolf, Z. Bukumirić, T. Radević, I. Salatić, B. Dujović, S. Matković, M. Djurkić, A. Ivezić, J. Filipović, B. Nikolin, N. Kolović,
    2026EJC Skin Cancer(2026)
    引用
    AI阅读
    加入学术空间
    3Characteristics and Survival Outcomes of Untreated, Resectable Stage I–III Melanoma Patients in Serbia
    I. Salatić, I. Tanasković, M. Recalde, B. Dujović, S. Matković, M. Đurkić, J. Filipović, A. Ivezić, B. Nikolin, N. Kolović, E. Milosavljević, M. Petronijević,
    2026EJC Skin Cancer(2026)
    引用
    AI阅读
    加入学术空间
    4Comparing Fibrinolytic Strategies in Intermediate-High-risk Pulmonary Embolism: Insights from a Multicenter Registry.
    Dzudovic Boris, Simpson Tamara,Matijasevic Jovan,Pekovic Sandra,Salinger Sonja,Miloradovic Vladimir,Kovacevic-Preradovic Tamara,Kos Ljiljana,Mitevska Irena, Mitrovic Bojan,Neskovic Aleksandar,Obradovic Slobodan
    2025Thrombosis research(2025)引用:1
    引用
    AI阅读
    加入学术空间
    5Trends in Pancreatic Cancer Mortality in Serbia: A Joinpoint Regression Analysis
    Sanja Ilic, Filip Dzudovic,Jovana Radovanovic,Viktor Selakovic, Emilija Subanovic, Natalija Djurovic, Dragana Andric, Zorana Babic, Svetlana Vukosavljevic, Maja Mirocevic Rotolo

    Pancreatic cancer is a significant public health problem worldwide. It is currently ranked as the 12th most common malignancy and the 6th leading cause of cancer mortality. This study aimed to investigate sex-specific and age-specific pancreatic cancer mortality trends and disparities in the Serbia from 2000 to 2021. A descriptive epidemiological population-based study analyzing pancreatic cancer mortality was conducted. Age-standardized mortality rates (ASMRs) were calculated using the Segi's world standard population. Temporal trends for pancreatic cancer mortality were assessed using the joinpoint regression analysis. Age-standardized rate of pancreatic cancer in Serbia was 6.4/100,000 (7.9/100,000 in men, 5.1/100,000 in women). The rates were found to be 1.6 times higher in men than women. Pancreatic cancer mortality trend significantly increased from 2000 to 2010 in men (APC=+2.4%, 95%CI: 0.3 – 1.4), after 2010 rates nonsignificantly decline (APC=−0.4%; (95%CI: −2.5 – 0.5). In women, mortality trend significantly increased by +1.8% at an annual level (95%CI: 0.7–2.7). The mortality of pancreatic cancer increased by age. The joinpoint analysis showed a significant rising trend of mortality rates in all age groups 60+, with the highest average annual percent change being reported in the age groups 85+ (AAPC=+3.1 (95%CI: 1.6–4.5)). The provision of updated statistics on the occurrence and outcomes of pancreatic cancer, time trends among various population groups, along with a better understanding of its etiology and identification of causal changeable risk factors – are essential when it comes to the primary prevention of this particular disease.

    2025Experimental and Applied Biomedical Research (EABR)(2025)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 426 篇论文

    合作机构(100)

    克拉古耶瓦茨大学合作论文 190
    贝尔格莱德大学合作论文 36
    Academy of Medicine合作论文 17
    Military Medical Academy合作论文 10
    University of Nis合作论文 9
    Children's Clinical University Hospital合作论文 8
    普里什蒂纳大学合作论文 5
    Mthatha General Hospital合作论文 5
    State University of Novi Pazar合作论文 4
    里耶卡大学合作论文 3

    机构统计